Delanzomib
Preliminary reference disclaimer
This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.
Preliminary safety reference
Available
Supplier-issued SDS
Available by request
COA
Available by RFQ / lot confirmation
Transport classification
Requires shipment review
CAS Number
847499-27-8
Chemical name
Delanzomib
Molecular formula
C21H28BN3O5
Molecular weight
413.3 g/mol
Synonyms
CEP 18770; NPH 007098; delanzomibum; CIP 18770; CT 47098; Boronic acid, ((1R)-1-(((2S,3R)-3-hydroxy-1-oxo-2-(((6-phenyl-2-pyridinyl)carbonyl)amino)butyl)amino)-3-methylbutyl)-; [(1R)-1-[(2S,3R)-3-hydroxy-2-[(6-phenylpyridin-2-yl)formamido]butanamido]-3-methylbutyl]boronic acid; ((1R)-1-((2S,3R)-3-HYDROXY-2-(6-PHENYLPYRIDINE-2-CARBOXAMIDO)BUTANAMIDO)-3-METHYLBUTYL)BORONIC ACID; ((1R)-1-((2S,3R)-3-hydroxy-2-((6-phenylpyridin-2-yl)formamido)butanamido)-3-methylbutyl)boronic acid; Proteasome Inhibitor CEP 18770; Delanzomib (CEP-18770); ((R)-1-((2S,3R)-3-Hydroxy-2-(6-phenylpicolinamido)butanamido)-3-methylbutyl)boronic acid
InChIKey
SJFBTAPEPRWNKH-CCKFTAQKSA-N
PubChem CID
24800541
Signal word
Warning
Catalog reference cue; confirm supplier documentation before use.
Hazard statements
H317, H319
Catalog reference cue; confirm supplier documentation before use.
Physical property reference values are not available in the current MolGraph catalog record.
Shipment review
Shipment details require review before fulfillment.
Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.